Utikal, Jochen 1974-
Jochen Utikal
Utikal, Jochen S.
VIAF ID: 268302420 (Personal)
Permalink: http://viaf.org/viaf/268302420
Preferred Forms
- 100 0 _ ‡a Jochen Utikal
- 100 1 _ ‡a Utikal, Jochen S.
-
- 100 1 _ ‡a Utikal, Jochen ‡d 1974-
- 100 1 _ ‡a Utikal, Jochen ‡d 1974-
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients | |
Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification | |
Deep learning can predict survival directly from histology in clear cell renal cell carcinoma | |
Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists | |
Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma | |
Effects of Label Noise on Deep Learning-Based Skin Cancer Classification | |
efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : a retrospective multicenter study | |
Eosinophils as biomarker in melanoma immunotherapy and solid tumors | |
Ethical challenges in cancer diagnosis and therapy, [2021]: | |
Gastrointestinal cancer classification and prognostication from histology using deep learning Systematic review | |
Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study | |
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis | |
Immunhistochemische Untersuchung prognostischer Marker beim malignen Melanom | |
The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study. | |
Improved survival with MEK inhibition in BRAF-mutated melanoma | |
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma | |
Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy | |
Leukocyte count restoration under dabrafenib treatment in a melanoma patient with vemurafenib-induced leukopenia: case report. | |
Local cutaneous argyria mimicking melanoma metastases in a patient with disseminated melanoma | |
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation | |
Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens. | |
Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives. | |
Model soups improve performance of dermoscopic skin cancer classifiers | |
Modeling short QT syndrome using human‐induced pluripotent stem cell–derived cardiomyocytes | |
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma | |
Molecular genetics of Xeroderma pigmentosum variant. | |
mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model | |
A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival | |
Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy. | |
Multiple highly and moderately differentiated squamous cell carcinomas of the skin during vismodegib treatment of inoperable basal cell carcinoma | |
Multiple roles of NF1 in the melanocyte lineage | |
Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib | |
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. | |
New role of ID3 in melanoma adaptive drug-resistance. | |
NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model. | |
Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation. | |
Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway | |
Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer | |
The oak processionary moth: a new health hazard? | |
Oncogenic role of an epigenetic reader of m6A RNA modification: YTHDF1 in Merkel cell carcinoma | |
The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians. | |
Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma | |
Persistent facial erythema and edema | |
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. | |
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma | |
PIEZO2 is required for mechanotransduction in human stem cell-derived touch receptors. | |
Predominant telangiectatic erythema in linear atrophoderma of Moulin: novel variant or separate entity? | |
Primary tumor–derived systemic nANGPTL4 inhibits metastasis | |
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. | |
Real-World Therapy with Pembrolizumab Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany | |
The receptor for interleukin-17E is induced by Th2 cytokines in antigen-presenting cells | |
Recurrent tattoo reactions in a patient treated with BRAF and MEK inhibitors | |
[Red and purple maculas and plaques at the lateral aspects of the thighs]. | |
Reiter's syndrome-like pattern in AIDS-associated psoriasiform dermatitis | |
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas | |
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression | |
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) | |
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study. | |
Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas. | |
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma | |
Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer. | |
Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytes | |
The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation | |
Single cell polarity in liquid phase facilitates tumour metastasis. | |
[Single center analysis of the dermatosurgical patient cohort of a tumor center in Germany] | |
Skin cancer classification via convolutional neural networks systematic review of studies involving human experts | |
SOX5 is involved in balanced MITF regulation in human melanoma cells. | |
STAT3 – the switch of melanoma-associated NRAS mutations | |
Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells. | |
Systemic therapy of non-resectable metastatic melanoma | |
T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin | |
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe) | |
Targeted Therapy-Resistant Melanoma Cells Acquire Transcriptomic Similarities with Human Melanoblasts | |
Targeting SOX2 in anticancer therapy | |
The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas. | |
TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells | |
Timed Ang2-targeted therapy identifies the Angiopoietin–tie pathway as key regulator of fatal lymphogenous metastasis | |
Topography of cancer-associated immune cells in human solid tumors | |
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial | |
Treatment of gunpowder tattoos with a high-speed diamond drill | |
Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany. | |
Unique Role of Histone Methyltransferase PRDM8 in the Tumorigenesis of Virus-Negative Merkel Cell Carcinoma | |
Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment | |
Willingness to pay for a cure of low-risk melanoma patients in Germany | |
Zweites Netzwerktreffen der zertifizierten Hauttumorzentren |